In order to study the presence of antibodies directed against Candida albicans 0-linked oligomannosides (oligomannosides 0) in patient sera, we have developed an enzyme-linked immunosorbent assay (ELISA) involving neoglycolipids constructed with these residues (NGLO). Oligomannosides 0 released by mild alkaline degradation of the C. albicans cell wall phosphopeptidomannan (PPM) contained one to seven mannose residues, among which the quantitatively major components, mannobiose and mannotriose, were shown by 'H nuclear magnetic resonance to contain exclusively a (1-2) linkages. The pool of oligomannosides was converted to neoglycolipids by coupling them to 4-hexadecylaniline in an equimolar reaction checked by thin-layer chromatography. We have tested against these neoantigens, coated on ELISA plates, 15 pairs of sera corresponding to individual seroconversions observed in 15 patients during the course of a mycological and serological survey of candidiasis. For all patients, seroconversions resulted in an increased level of antibodies against NGLO. A significant correlation was observed between the results of ELISA-NGLO, ELISA involving the original PPM molecule, and routine antibody detection tests, indirect immunofluorescence assay, and cocounterimmunoelectrophoresis. These results therefore demonstrate the synthesis of human antibodies reactive with oligomannosides 0 constitutive of the C. albicans mannan molecule which have been previously described as exhibiting an inhibitory effect on human lymphocytic proliferation.
Candida albicans mannan polysaccharide is a major component of the cell wall whose importance in the physiopathology of candidiasis has been the subject of extensive studies. It has been shown that mannans determine the antigenic specificity of Candida species and C. albicans serotypes as analyzed with polyclonal-adsorbed antibodies (11, 29) . Antimannan antibodies are present in the sera of most healthy individuals (2) and show an increase during development of invasive candidiasis in immunocompetent patients (15) . Furthermore, antimannan polyclonal (1) or monoclonal (10, 19) antibodies allow the detection of antigenemia in sera from patients with systemic Candida infection. Finally, bioclinical and experimental evidence indicates that mannan is a potent immunomodulator (4) .
Recent refinements in methods for fractionation and structure determination have led to the description of a model for the structure of these cell wall matrix components extracted by autoclaving and corresponding to phosphopeptidomannan (PPM) (12, 25, 26) . The polysaccharide moiety of the PPM molecule is linked to the peptide via asparagine (Nglycoside part) and serine or threonine residues (O-glycoside part). The N-glycoside part is composed of a highly branched chain of mannopyrannosyl residues linked by a(1-6) bonds to which are attached oligosaccharide side chains, where mannopyrannosyl residues are linked through ot(1-2), a(1-3), P(1-2), P(1-6), and phosphodiester bonds (7, 8, 12, 14) . The O-glycoside component appears to consist of shorter and unbranched chains (18) . * Corresponding author.
Experimental evidence indicates that individual oligomannosides obtained by depolymerization of the PPM molecule represent epitopes which have been described as the basis of rabbit polyclonal-antibody specificities (7, 28) . These conclusions were reached by application of inhibition reactions in liquid phase (7, 8, 17) . These techniques, which are not well adapted to the multivalent character of immunoglobulin M (IgM), the predominant isotype against polysaccharides, require large quantities of purified oligomannosides and are poorly adapted to extensive screenings. At the moment, because of the lack of appropriate methodology, recognition by human antibodies of the C. albicans oligomannoside repertoire present in the mannan molecule is virtually unknown. We have recently developed a method to render oligomannosides antigenic by coupling them to a carrier molecule able to bind to a conventional substrate for immunoanalysis (Sa, 6). The oligomannosides are coupled to a lipid, 4-hexadecylaniline, according to a method leading to a mole-to-mole binding whose efficiency can be vizualized and assessed after thin-layer chromatography. The purpose of this work was to use this method to determine if the 0-linked oligomannosides, which have been recently demonstrated as exhibiting an inhibitory effect on human lymphocytic proliferation induced by Candida and other antigens (18) , elicit an antibody response during invasive candidiasis. 0-linked oligomannosides, released from the PPM molecule by ,B elimination, were analyzed by thin-layer chromatography and 'H nuclear magnetic resonance (NMR) (for the two major oligomannosides) before being converted to neoglycolipids (NGL) containing 0-linked oligomannosides (NGLO). NGLO were coated on plates for an enzyme-linked immunosorbent assay, and their antigenicity was studied by probing them with human sera. These sera were retrospectively selected from hospital inpatients who had seroconverted during the course of a mycological and serological survey for candidiasis by indirect immunofluorescence assay (IFA) and cocounterimmunoelectrophoresis (Co-CIE) procedures (20 . Two sera were selected for each of the 15 patients: one from before and one from after seroconversion. As a positive control (C), we used the serum from a patient who had presented with C. albicans septicemia proved by three successive positive blood cultures and who exhibited high levels of antibody against C. albicans.
Routine serological tests. (i) IFA. IFA was performed with C. albicans VW 32 blastoconidia (20) . Standardization of this test was achieved by the use of a pool of sera from patients with candidiasis (Bio-Merieux, Marcy l'Etoile, France). A titer equal to or greater than 400 is considered indicative of candidiasis.
(ii) Co-CIE. Co-CIE with a soluble extract of VW 32 blastoconidia was used to detect precipitating antibodies presenting a line of identity with an anti-VW 32 germ tube antiserum (20) . This line of identity is named the cospecific precipitin line (CSPL). Interpretation of Co-CIE results refers to presence or absence of CSPL and quantitative evolution of the CSPL (migration towards the cathode which increases in intensity for successive sera from the same patients). Quantification of the results obtained by Co-CIE was needed for statistical analysis, and results were expressed through scores defined as follows: 0, absence of precipitin line; 1, faint, nonspecific precipitin line; 2, one nonspecific precipitating line; 3 to 7, presence of CSPL with increasing intensities.
Obtainment and analysis of 0-linked oligomannosides. (i) Production of PPM. PPM was extracted from yeast cells grown in bioreactors according to the method described by Kocourek and Ballou (13) . The procedure was modified in that a single extraction in citrate buffer was made (6) .
(ui) Mild acid hydrolysis. According to the method of Faille et al. (6) , 1 g of PPM was dissolved in 50 ml of HCI (0.01 N), and the solution was heated at 100°C for 30 min. After cooling, the solution was neutralized with NaOH and lyophilized.
(iii) Mild alkaline hydrolysis. According to a method adapted from that of Nakajima and Ballou (16) , 585 mg of PPM depleted of oligomannosides after mild acid hydrolysis was dissolved in 50 ml of NaOH (0.1 N), incubated for 24 h at 25°C under agitation, and then neutralized with acetic acid (1 N) and lyophilized.
(iv) Gel filtration chromatography. After each hydrolysis, the products were dissolved in water and settled on Bio-Gel P4 (Biorad, Herdfordshire, England) columns (1.8 by 150 cm). The columns were eluted with distilled water at a flow rate of 5 ml/h at room temperature. Fractions (2 ml) were collected and analyzed by thin-layer chromatography.
(v) Thin-layer chromatography. The oligosaccharides were separated on Silica Gel 60-precoated plates (Kieselgel 60, Merck, Darmstadt, Germany) with n-butanol-acetic acidwater (20/10/10, vol/vol/vol) as a solvent. The oligosaccharides were stained with a solution of orcinol ( Construction and analysis of NGLO. Construction and analysis of NGLO were carried out according to a previously described method (6) . Briefly, 100 mg of 4-hexadecylaniline (Aldrich Chemical Co., Milwaukee, Wis.) was added to 500
[LI of a solution containing 35 mg of sodium cyanoborohydride, 3.5 ml of methanol, and 400 RI of acetic acid. The solution was heated at 80°C, and 1 mg of 0-linked oligomannosides solubilized in 50 ,ul of water was added to 200 RI of this solution and incubated at 80°C for 90 min. The solution was cooled, mixed with chloroform and water added in equal parts, and centrifuged. The aqueous phase was dried, dissolved in methanol (2 ml), and centrifuged. The supernatant containing the NGLO was conserved.
ELISA procedure. The ELISA involved PPM and NGLO coated onto 96-well polystyrene plates (Nunc Immuno Type II).
The method was set up, as previously described for a different pool of oligomannosides, by analyzing the reactivity of three patient sera with different IFA titers (5a). For given concentrations of human antibodies and conjugates, the elevation in optical density (OD) was related to the quantity of PPM and NGLO until a maximum was reached. We chose for both antigens the carbohydrate concentration giving the best discrimination between sera with different IFA titers. As before (5a), at these concentrations of antigen and neoantigen, reactions with antibodies were found as to be dose dependent and saturable.
Application of these analyses led to the definition of the following methods as routine procedures. They were used throughout the study.
For NGLO, each well received 50 ,ul of a 10-,ug/ml solution of antigen in carbonate buffer (60 mM, pH 9.6). Plates were incubated for 1 h at 37°C and overnight at 4°C and then washed five times in TNT buffer (Tris, 50 mM; NaCl, 150 mM; HCI [pH 7.5]; Tween 20, 0.05%). The last wash was prolonged for 5 min. The plates were stored at -20°C. All wells were saturated with a bovine serum albumin (Boehringer, Mannheim, Germany) solution diluted to 3% in TNT buffer lacking Tween. 50-pI volume of 1/1,000 serum diluted in TNT buffer was incubated in each well for by alkaline degradation (P elimination) on PPM depleted in oligosaccharides linked through phosphodiester bonds by mild acid hydrolysis. Oligosaccharides were desorbed from a Bio-Gel P4 column (1.8 by 150 cm). Seven spots, corresponding to oligosaccharides containing one to seven mannose residues, can be seen. Three controls were used: mannose (M), saccharose (S), and raffinose (R). The arrow at the bottom indicates the point of application.
ELISA procedure using PPM antigen coated on ELISA plates was similar except that (i) plates were coated with 100 ,ul of a 1-,ug/ml solution of PPM, (ii) human sera (100 ,ul) were used at a dilution of 1/8,000, and (iii) peroxidase-labeled antibody (100 ,u) was used at a dilution of 1/1,000.
Statistical analyses. Correlations between results obtained with all serological procedures on the 30 sera were studied after a variable transformation for variance homogeneity (27) . The correlation coefficients were analyzed by the t test (23) . RESULTS Analysis of oligosaccharides released by mild alkaline degradation. Thin-layer chromatography of oligosaccharides released by elimination showed the presence of oligosaccharides with one to seven mannose residues (Fig. 1) . The quantitatively major components were mannobiose and mannotriose.
'H NMR analysis of mannobiose and mannotriose. The NMR spectra of mannobiose and mannotriose (Fig. 2) were assigned by the method of Cohen and Ballou (3) . For the mannobiose, the anomeric protons were observed at 8 = 5.043 ppm (terminal mannose B) and 5.378 ppm (reducing mannose A, a anomer) (Fig. 2A) . The coupling constants were 1.8 Hz for B and Aa and 1.1 Hz for AP. For the mannotriose, the anomeric protons were found to resonate at 5.045 ppm (terminal mannose C), 5.297 ppm (internal mannose B), 5.368 ppm (reducing mannose a), and 4.911 (reducing mannose P) (Fig. 2B) . The coupling constant observed for the C, B, and Aa signals was 1.8 Hz, which confirms the a anomery. The results confirmed the structure of the two 0-linked oligosaccharides as Man(al-2)Man and Man(al-2)Man(al-2)Man. Analysis of NGL. The pool of NGLO was analyzed by thin-layer chromatography. Individual components were visualized either under UV light, according to their lipid moieties (Fig. 3) , or after orcinol staining according to their carbohydrate moieties (data not shown). Seven bands were identified. They were interpreted as resulting from the migration of Mannose-4hexadecylaniline to Mannohexaose- (Table 1) , corresponded to an increase of the ELISA signal against NGLO (Fig. 4) . Strong differences were observed in the intensity of the ELISA signal between individual patients either before or after seroconversion. The OD for sera drawn before seroconversion were usually very low, ranging from 0.005 to 0.098, whereas the OD for sera taken after seroconversion ranged from 0.086 to 0.499. The levels of both ELISA signals were apparently irrelevant to the mycological data. However, an increase in OD against the neoantigen was systematically observed for any couple of sera, each patient being his own control, confirming the antigenicity of NGLO.
(ii) Statistical analyses of serological tests. Variable transformation for variance homogeneity in relation to IFA titers led us to express the results of all serological tests except Co-CIE by their logarithms. Linear regression analysis (Fig.  5 ) demonstrated the existence of a correlation between ELISA-NGLO and IFA (Fig. 5A) , Co-CIE (Fig. 5B) , and ELISA-PPM (Fig. 5C) . The 0,2-0 of the C. albicans oligomannoside repertoire are presently restricted to antisera studied in highly specialized laboratories able to produce and analyze large quantities of oligomannosides (7). Faced with this problem, we have recently developed a method of construction of NGL from oligomannosides released by sequential depolymerization of the PPM. Such neoantigens have been shown in experimental models to exhibit immunogenicity and antigenicity (6) , mimicking the activity of C. albicans natural antigens. NGL coated on ELISA plates have also been shown to react with mammalian polyclonal or monoclonal immunoglobulins reacting with the original PPM, according to dose-dependent and saturable reactions (5a).
In the present work, this method has been applied to the study of human antibodies able to react with the family of oligomannosides linked to the PPM molecule by O-glycoside linkages and released after ,3 elimination (16). Mild alkaline degradation of C. albicans mannan, previously depleted in oligomannosides attached through phosphodiester bonds, led to the release of 0-linked oligomannosides containing one to seven mannose residues. The structural determination of the major oligomannosides, mannobiose and mannotriose, demonstrated the presence of (al-2) linkages. These results are similar to those obtained by Podzorski et al. with another C. albicans strain (18) , except that those authors described only six oligomannosides. Thin-layer chromatography analysis of oligosaccharides after they were coupled to 4-hexadecylaniline allowed the efficiency of the binding to be visualized and assessed. Each coupled oligomannoside except the mannobiose appeared on the chromatogram as a single band; the mannobiose gave two bands. The most likely hypothesis to explain this observation would be related to the aglycone part of NGL, the aqueous solvent triggering two different ionizations. This phenomenon hap- pened only for coupled mannobiose, the other oligommanosides being too heavy to be separated on thin-layer chromatograms according to their ionization patterns.
Despite the fact that an immunomodulatory role of C. albicans 0-linked oligomannosides against human lymphocytic proliferation induced in vitro (18) has been demonstrated, it was not known if these structures could react with antibodies. From a physiopathological point of view, the existence of antibodies reacting with these oligomannoside species is an important consideration, since the antibodies may interfere with the direct triggering of lymphoid cells induced by these potential epitopes. The demonstration of the existence of human antibodies able to react with 0-linked oligomannosides through conventional methods of precipitation inhibition is in practice unrealizable because of the amount of oligomannosides required for such experiments (7, 17) . Considering this lack of methodology adapted to extensive screenings of C. albicans oligomannoside reactivity with human and animal antibodies, we have recently developed a method for constructing NGL from these residues. Following application of this method, oligomannosides from various families (5a, 6) have been shown to bind to conventional substrates for immunoanalysis through their lipid carrier molecule and to be able to react with antibodies according to dose-dependent and saturable reactions (5a). Construction of NGL from C. albicans 0-linked oligomannosides provided, for the first time, evidence of human antibodies reacting with these residues. Evidence came both from increased ELISA-NGLO signals following individual seroconversions and from the close correlation observed between reactivity of sera against NGLO and PPM. Despite individual differences, whose diagnostic and prognostic significance remains presently unclear, reactivity of patient sera against neoantigens evaluated as a whole did not significantly differ from that against the PPM from which the neoantigens were derived. These results are compatible with what is known about the structure of 0-linked oligomannosides composed of Man a (1-2) and Man a (1-3) linkages largely distributed through the N-linked part of the PPM molecule (24) ; in the same way, the use of PPM depleted in 0-linked oligomannosides did not significantly affect PPM reactivity against patient sera (unpublished data). It is also consistent with the experimental evidence reported by Shibata et al. (26) that, in contrast to mild acid hydrolysis, P elimination did not affect the precipitating effect of antibodies raised against different C. albicans serotypes. Therefore, according to this lack of structural specificity of C. albicans 0-linked oligomannosides, it is impossible at the present stage of this work to say if the antibody response demonstrated here resulted from specific triggering of the human immune system by these molecules or represented crossreactivity with antibodies generated against similar structures by other oligomannoside species of the mannan molecule.
The acknowledged risk of our immunochemical approach, which also exists with the precipitation inhibition reactions in liquid phase used as a reference (7), is that neoantigens could suffer chemical alterations during preparation procedures so that their conformation would not mimic the natural antigen. In this respect, the correlation observed between the ELISA-PPM and ELISA-NGLO has been encouraging. As an incidental finding, statistical analysis revealed no interference between the results obtained and antigenemia, as revealed by the Cand-tec test (9) in sera from 12 patients (data not shown). Despite slight differences between individual antibody detection tests which appeared when the tests were compared two by two after an adapted variable transformation, a good overall correlation was nevertheless observed between them. This is not surprising, since all these tests detect antibodies against C. albicans mannoproteins according to their precipitation with a whole-cell extract (20) , their reactivity with the cell wall surface (22) , or their reactivity with the PPM extracted from the surface and deeper layers of the cell wall (21) . Construction of NGL therefore provides a way for the determination of the molecular basis of the human antibody response against cell wall mannan, which has so far been appreciated as a whole. This analysis is currently being extended to other oligomannoside families to determine the prognosis and diagnostic significance of their recognition by human immunoglobulin isotypes.
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